Optimising well-being in myasthenia gravis: a multidisciplinary approach

Area of Science:

• Neurology
• Internal Medicine
• Patient Health

Background:

• Myasthenia gravis (MG) primarily presents with muscle weakness.
• MG and its treatments are associated with significant comorbidities impacting patient well-being.
• These comorbidities include secondary autoimmunity, cardiovascular and endocrine issues, fatigue, sleep, and mental health disorders.

Purpose of the Study:

• To review the multi-morbid nature of myasthenia gravis.
• To provide an approach for recognizing and managing comorbidities in MG patients.
• To emphasize preventative health strategies for individuals with MG.

Main Methods:

• Literature review of existing studies on myasthenia gravis comorbidities.
• Analysis of the impact of MG and its treatments on patient quality of life.
• Development of a management framework for associated health conditions.

Main Results:

• Myasthenia gravis is frequently accompanied by a wide range of comorbid conditions.
• These comorbidities significantly affect patients' quality of life and can impose social and economic burdens.
• Effective management requires a comprehensive approach addressing both MG and its associated conditions.

Conclusions:

• Recognizing and managing comorbidities is crucial for improving the overall health and quality of life for myasthenia gravis patients.
• A proactive, preventative healthcare strategy is essential.
• Integrated care addressing the multi-morbid nature of MG is recommended.